Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7384
    -0.0002 (-0.03%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    95,355.16
    -901.79 (-0.94%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,379.46
    -20.06 (-0.12%)
     
  • VOLATILITY

    13.01
    0.00 (0.00%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • CAD/EUR

    0.6836
    -0.0007 (-0.10%)
     

New Strong Sell Stocks for June 2nd

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Ono Pharmaceutical Co., Ltd. OPHLF is a company that produces purchases and sells pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals. The Zacks Consensus Estimate for its current year earnings has been revised 2.1% downward over the last 60 days.

Tokyo Electron Limited TOELY is a company mainly engaged in the manufacture and sale of electronic products for industrial uses. The Zacks Consensus Estimate for its current year earnings has been revised 14.2% downward over the last 60 days.

Tilly's, Inc. TLYS is a specialty retailer in the action sports industry selling clothing, shoes and accessories. The Zacks Consensus Estimate for its next quarter earnings have been revised 50.0% downward over the last 60 days.

ADVERTISEMENT

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Ono Pharmaceutical Co. (OPHLF) : Free Stock Analysis Report

Tokyo Electron Ltd. (TOELY) : Free Stock Analysis Report

Tilly's, Inc. (TLYS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research